EGFR inhibitor as second-line therapy in a patient with mutant RAS metastatic colorectal cancer: circulating tumor DNA to personalize treatment [PDF]
, 2018 A 47-year-old male patient presented in March 2016 to our unit with a palpable painless left supraclavicular mass. A whole-body contrastenhanced computed tomography (CT) scan revealed a left supraclavicular lymphadenopathy, transverse colon thickening ...
Cortesi, Enrico +3 more
core +1 more source
Risk Scoring System to Predict Mortality in Gastric Cancer with Peritoneal Carcinomatosis. [PDF]
Med Sci (Basel)Pereira MA +4 more
europepmc +3 more sources
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer [PDF]
, 2017 Background: More information is needed for selection of patients with peritoneal metastases from endometrial cancer (EC) to undergo cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: This study analyzed clinical,
Biacchi, Daniele +9 more
core +1 more source
Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
Креативная хирургия и онкология, 2021 Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy.
Sh. Kh. Gantsev +3 more
doaj +1 more source
Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial [PDF]
, 2011 Background: Peritoneal carcinomatosis (PC) is common in gastrointestinal (GI) cancer and there is no effective standard treatment. We investigated the tolerability and maximum tolerated dose (MTD) of the trifunctional antibody catumaxomab in patients ...
Grützner, Klaus-Uwe +10 more
core +1 more source
Textbook outcome in ovarian cancer and its impact on survival: comparative study
World Journal of Surgical OncologyIntroduction Patients who achieve the textbook outcome (TO) present an uneventful postoperative course. Obtaining TO has also been related to better survival in oncological patients.
Silvia Carbonell-Morote +9 more
doaj +1 more source
Experimental Modeling and Treatment Strategies for Peritoneal Carcinomatosis
Turkish Journal of Colorectal DiseasePeritoneal carcinomatosis (PC), associated with a range of gastrointestinal and gynecological malignancies, represents a significant condition characterized by the dissemination of cancer cells within the peritoneal cavity.
Aras Emre Canda, Tolga Sever
doaj +1 more source
Advanced Science, EarlyView.This study presents a glutathione (GSH)‐activatable dual‐modality probe (GAP9) with a redox‐tuned activation window for precise tumor detection. It remains quenched (“OFF”) in normal tissue yet activates specifically in tumors for T1‐weighted magnetic resonance imaging (MRI) preoperative mapping and near‐infrared II (NIR‐II) fluorescence intraoperative
Haohao Yan +4 more
wiley +1 more source
Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment
BMEMat, EarlyView.Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan +8 more
wiley +1 more source
CT mimics of peritoneal carcinomatosis
Indian Journal of Radiology and Imaging, 2010 Peritoneal carcinomatosis is a term used to describe widespread metastases of cancerous tumors in the peritoneal cavity. It is most common in carcinomas of the gastrointestinal tract (GIT) and ovaries, and must be considered to be the main diagnosis even
Smiti S, Rajagopal K
doaj +3 more sources